Headache

Article	Citations
Facial variant of epicrania fugax secondary to a cerebellopontine angle meningioma	115
Erratum	96
Characteristics associated with response to subcutaneously administered anti‐CGRP monoclonal antibody medications in a real‐world community cohort of persons living with migraine: A retrospective clin	76
A retrospective analysis of the use of candesartan for migraine prevention in adolescents	56
Popping the balloon: Abrupt onset of a spinal CSF leak and spontaneous intracranial hypotension in idiopathic intracranial hypertension, a case report	55
Normal glymphatic system function in patients with new daily persistent headache using diffusion tensor image analysis along the perivascular space	40
Identifying cognitive‐affective mechanisms underlying disability in episodic migraine: Using the fear avoidance model to examine interactions	38
Evidence for increased background neural noise in migraine with aura: Hyperactive but not hyperresponsive	37
A 52‐week open‐label extension study to evaluate the safety and efficacy of oral rimegepant for the preventive treatment of migraine	35
Effect of caffeine and caffeine cessation on cerebrovascular reactivity in patients with migraine	34
Migraine treatment in pregnancy: A survey of comfort and treatment practices of women's healthcare providers	31
Persistence, effectiveness, and tolerability of anti‐calcitonin gene–related peptide monoclonal antibodies in patients with chronic migraine	30
Post‐traumatic headache: An unmet medical need	28
Genetic migraine disorders and the response to calcitonin gene‐related peptide antagonist treatment	28
Assessing the influence of migraine on ischemic penumbra and on the prognosis of ischemic stroke: A prospective cohort study	28
Pilot study evaluating treatment with sumatriptan for moderate to severe post‐traumatic headache: A phase 2 open‐label study	28
Drug‐resistant epicrania fugax: Responding to onabotulinumtoxinA	27
Migraine screening in English and Spanish	27
A retrospective review of sex differences of white matter hyperintensities in brain MRI of patients with migraine	26
Migraine and peripheral pain models show differential alterations in neuronal complexity	26
The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine	26
Virtual issue: Education in headache medicine: Insights and advancements from 2023 to 2024	26
Patient headache questionnaires can improve headache diagnosis and treatment in children	26
Anxiety, depression, and headache‐related disability in a large pediatric clinic–based sample	26
Effect of erenumab versus other migraine preventive medications on cardiovascular and cerebrovascular outcomes: A United States claims database‐based observational cohort study	25

Skin wetness sensitivity across body sites commonly affected by pain in people with migraine	25
Sequential administration of peripheral nerve blocks and onabotulinumtoxinA for the treatment of chronic migraine and other headache disorders—A retrospective tolerability and safety study	25
Index	25
Long‐term efficacy and safety of erenumab in patients with chronic migraine and acute medication overuse: A subgroup analysis	24
Effects of fremanezumab on migraine‐associated symptoms and medication use in Japanese and Korean patients with episodic migraine: Exploratory endpoint analysis of a multicenter, randomized, double‐bl	24
The teaching of headache medicine in France: A questionnaire‐based study	24
Clinical characteristics and perfusion‐computed tomography alterations in a series of patients with migraine with aura attended as stroke code	24
Patient preference for early onset of efficacy of preventive migraine treatments	23
Patient‐reported experiences with migraine‐related cognitive symptoms: Results of the MiCOAS qualitative study	22
Crystal‐clear days and unclear days in migraine: A population‐based study	22
Sex and gender: Opportunities to expand research and understanding within headache medicine	22
Developing and delivering a migraine disparities and diagnosis undergraduate medical educational program to underrepresented in medicine medical student members of the Student National Medical Associa	22
Headache and psychological variables as predictors of disability in individuals with primary headache disorders	21
TRPM3 activation causes CGRP release in trigeminal neurons: Implications for migraine mechanisms	21
Neuromodulation for primary headache disorders: Advantages and challenges	21
Prevalence of primary stabbing headache: A meta‐analysis	21
Dietary sodium and headache are linked by cerebrospinal fluid sodium concentration to sodium‐specific appetite, tolerance, and perceptive reward	21
Patients with chronic post‐dural puncture headache do not have typical imaging features of intracranial hypotension: An MRI study using the Bern scor	21
Issue Information	20
Issue Information	20
CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivity	20
	20
Challenges and opportunities for estimating and assessing migraine prevalence, incidence and impact across study populations and methodologies: Bridging global and United States findings	20
Post‐vaccination headache reporting: Trends according to the Vaccine Adverse Events Reporting System	20
Headache and acute cerebrovascular disease: How do we differentiate primary and secondary headache disorders in the emergency setting?	20
The elephant in the room: How the underfunding of headache research stunts the field	20
Changes in cognitive appraisal in a randomized controlled trial of mindfulness‐based cognitive therapy for patients with migraine	18
Assessing blood pressure changes and hypertension‐related outcomes in patients with migraine treated with erenumab: A systematic review and meta‐analysis	18
Evaluation of vascular risk in patients with migraine with and without aura treated with erenumab: Post hoc analysis of pooled long‐term clinical trial data	18
The 2024 Headache editorial board Conflict of Interest Declarations	17
Protracted headache after COVID‐19: A case series of 31 patients from a tertiary headache center	17
OnabotulinumtoxinA as a promising treatment for primary trochlear headache: A retrospective case series	17
Prevalence, characteristics, and factors associated with caffeine‐withdrawal headache during the first day of Ramadan	17
Alcohol as a trigger of migraine attacks in people with migraine. Results from a large prospective cohort study in English‐speaking countries	16
Treatment effectiveness of galcanezumab versus traditional oral migraine preventive medications at 3 months: Results from the TRIUMPH study	16
Recurrent painful ophthalmoplegic neuropathy with headache and oculomotor palsy 18 years apart	16
Dystonia phenomenology and treatment response in migraine	16
Sustained benefits of onabotulinumtoxinA treatment in chronic migraine: An analysis of the pooled Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) randomized controlled trials	16
Remote electrical neuromodulation to treat children and adolescents with migraine in the emergency department: A randomized double‐dummy pilot trial	16
Validation of a Portuguese version of the four‐item Migraine Interictal Burden Scale	16
Socioeconomic and geographic inequalities in headache disability in Brazil: The 2019 National Health Survey	16
Different dosage regimens of erenumab for the treatment of migraine: A systematic review and meta‐analysis of the efficacy and safety of randomized controlled trials	15
The cortical spreading depression/migraine aura hypothesis – Finally some definitive evidence	15
Effect of galcanezumab in women with episodic migraine meeting criteria for menstrually related migraine: A post hoc analysis of EVOLVE‐1 and EVOLVE‐2	15
Issue Information	15
Issue Information	15
Plain Language Summary Publication: Investigating the causal and genetic relationship between migraine and Parkinson’s disease	15
Red flags in headache care	15
Burden of migraine in Brazil: A cross‐sectional real‐world study	15
A large language model–based generative natural language processing framework fine‐tuned on clinical notes accurately extracts headache frequency from electronic health records	15

Melatonin for migraine prevention in children and adolescents: A randomized, double‐blind, placebo‐controlled trial after single‐blind placebo lead‐in	15
Prediction of individual trigeminal pain sensitivity from gray matter structure within the sensorimotor network	15
Afterimage duration differs for migraine with or without aura	15
The 2025 Headache Editorial Board conflict of interest declarations	14
Development and pharmacological characterization of novel multi‐ calcitonin gene‐related peptide and pituitary adenylate cyclase‐activating peptide receptor antagonists	14
Eicosapentaenoic acid versus placebo as adjunctive therapy in chronic migraine: A randomized controlled trial	14
Essential components of care in a multidisciplinary headache center: Perspectives from headache neurology specialists	14
Clinical factors associated with day‐to‐day peak pain severity in individuals with chronic migraine: A cohort study using daily prospective diary data	14
Challenges in the management of new daily persistent headache at a tertiary headache center—A retrospective real‐world evidence study	14
Emergency department utilization among patients who receive outpatient specialty care for headache: A retrospective cohort study analysis	14
Headache in individuals undergoing hormone therapy for gender transition: A cross‐sectional, observational study	14
Intracranial hypotension as a contributor to isolated cortical vein thrombosis	13
Comparison and predictors of chronic migraine vs. new daily persistent headache presenting with a chronic migraine phenotype	13
Plain Language Summary Publication: The 2023 protocol for update to acute treatment of adults with migraine in the emergency department: The American headache society evidence assessment of parenteral	13
Clinical characteristics and patient‐reported outcomes of chronic and episodic migraine patients at a US tertiary headache center: A retrospective observational study	13
Secondary nummular headache: Are they more common than we thought?	13
Effect of wildfire smoke on primary headache disorders remains unclear	13
Beyond aura: Understanding migraine as a cycling pan‐sensory threshold disease	13
Characterization of trigeminal C‐fiber reactivity through capsaicin‐induced release of calcitonin gene‐related peptide	13
	13
Essential but often overlooked reporting elements for Headache manuscripts	13
Decision‐making impairment under ambiguity but not under risk may underlie medication overuse in patients with chronic migraine	13
Digital headache self‐management interventions for patients with a primary headache disorder: A systematic review of randomized controlled trials	13
Are psychological interventions efficacious for adults with migraine? A systematic review and meta‐analysis	13
Long‐term effectiveness of eptinezumab in the treatment of patients with chronic migraine and medication‐overuse headache	12
Basic Science Prize Award 2024	12
American Headache Society 64th Annual Scientific Meeting June 9–12, 2022 Denver, Colorado	12
Factors associated with efficacy of occipital nerve stimulation in medically intractable chronic cluster headache	12
Plasma calcitonin gene–related peptide and nerve growth factor as headache and pain biomarkers in recently deployed soldiers with and without a recent concussion	12
Headache in transgender men using gender‐affirming hormone therapy: A case–control study	12
Zavegepant nasal spray for the acute treatment of migraine: A Phase 2/3 double‐blind, randomized, placebo‐controlled, dose‐ranging trial	12
The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice	12
Arachnoid granulations in idiopathic intracranial hypertension: Do they have an influence?	12
Reducing the physical, social, and emotional impact of episodic migraine: Results from erenumab STRIVE and ARISE phase III randomized trials	12
Efficacy and safety of rimegepant for the acute treatment of migraine in Japan: A dose‐ranging, double‐blind, randomized controlled trial	11
Mechanisms of change in posttraumatic headache–related disability: A mediation model	11
Plain Language Summary Publication: Evaluating the use of paracetamol to prevent fasting headache during the first week of Ramadan: A randomized, open‐label, clinical trial	11
The pathogenic role of calcitonin gene‐related peptide and predictors of new‐onset migraine and long‐term outcomes after transcatheter atrial septal defect closure	11
Time to reconsider the association between migraine and white matter hyperintensities?	11
Blink reflex: A practical test to evaluate the trigeminal nerve injury following percutaneous balloon compression for the treatment of trigeminal neuralgia	11
Improving distress perception and mutuality in migraine caregivers after 6 months of galcanezumab treatment	11
Migraine epidemiology in collegiate student‐athletes: Findings from the Concussion Assessment, Research, and Education (CARE) Consortium	11
Beyond movement: Headache in patients with functional movement disorders	10
Development and validation of a novel patient‐reported outcome measure in people with episodic migraine and chronic migraine: The Activity Impairment in Migraine Diary	10
The impact of updates in headache quality measures on adherence to best practices in a neurology resident clinic: A quality improvement study	10
Post hoc analysis of clinical trial data and pharmacokinetic data to assess wearing‐off of erenumab within monthly treatment cycle	10
The link between reversible cerebral vasoconstriction syndrome and transient global amnesia	10
Migraine and infertility, merging concepts in women's reproductive health: A narrative review	10
Glial activation in pain and emotional processing regions in the nitroglycerin mouse model of chronic migraine	10
Visual hypersensitivity in patients treated with anti‐calcitonin gene–related peptide (receptor) monoclonal antibodies	10
Validity of self‐reported migraine in adolescents and children	10
Exploring the impact of acute SARS‐CoV‐2 infection on headache pattern in patients with migraine: A novel Bayesian analysis	10
Issue Information	10
The Chronic Headache Self‐Efficacy Scale: Development and assessment of measurement properties	9
Cerebrovascular reactivity to hypercapnia in patients with migraine: A dual‐echo arterial spin labeling MRI study	9
	9
Response to: Disagreement with Categorization of Clinical Trials included in Treadwell et al. Systematic Review and Meta‐Analysis	9
Issue Information	9
Cluster Analysis of Migraine‐associated Symptoms (CAMS) in youth: A retrospective cross‐sectional multicenter study	9
	9
Heavy metal and trace element alterations in patients during a migraine attack	9
Counting the cost: How migraine shapes lives and economies	9
Causal associations between genetically predicted placental weight and migraine	9
	9
Magnetoencephalography studies in migraine and headache disorders: A systematic review	9
Insomnia severity in migraine: The role of headache frequency, aura status, and comorbidities—A cross‐sectional study	9
The importance of patient and family perspectives of clinical decisions in pediatric headache	9
Celebrating Headache's 2023 graduating class of Assistant Editors	9
A post hoc analysis of migraine‐associated symptoms from the phase 3 randomized, double‐blind, sham‐controlled Trial of External trigeminal nerve stimulation for the Acute treatment of Migraine (	9
Migraine in the context of chronic primary pain, chronic overlapping pain disorders, and functional somatic disorders: A narrative review	9
Correction to “Smartphone‐delivered progressive muscle relaxation for the treatment of migraine in primary care: A randomized controlled trial”	9
A randomized trial of ketorolac and metoclopramide for migraine in the emergency department	9
Migraine, idiopathic intracranial hypertension, and calcitonin gene‐related peptide antibodies	9
Letter to the Editor regarding “Impact of perilesional edema on severity of migraine in patients with calcified neurocysticercosis: A prospective evaluation”	8
Exploratory investigation of a patient‐informed low‐dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double‐blind, placebo‐controlled trial	8
Patient headache questionnaires can improve headache diagnosis and treatment in children	8
Effectiveness and tolerability of galcanezumab for migraine prevention in patients ≥65 years: A real‐life multicenter study	8
Headache basic science prize	8
Comparative prevalence and characteristics of fabricated citations in large language models in headache medicine	8
	8

Real‐world barriers to health care utilization among people living with migraine: Insights from the All of Us Research Program	8
Identifying and predicting headache trajectories among those with acute post‐traumatic headache	8
Issue Information	8
A critical appraisal of the International Classification of Headache Disorders migraine diagnostic criteria based on a retrospective multicenter cross‐sectional headache registry study in youth	8
Headache diagnosis and treatment: A pilot knowledge and needs assessment among physical therapists	8
Indomethacin‐responsive idiopathic red ear syndrome: A pediatric case	8
Trainee highlights	8
Heightened migraine risk in patients with rheumatoid arthritis: A national retrospective cohort study	8
Long‐term evolution of white and gray matter structural properties in migraine	8
Issue Information	8
Symptomatic visual snow in acute ischemic stroke: A case series	8
The effectiveness of parenteral agents for pain reduction in patients with migraine presenting to emergency settings: A systematic review and network analysis	8
	8
Intranasal treatment of cluster headache: A response	8
Virtual issue: Recent advances in pediatric headache: Bridging the data gap	8
	8
Circadian functional changes of pain‐processing brainstem nuclei and implications for cluster headache: A 7 Tesla imaging study	8
Machine learning models and classification algorithms in the diagnosis of vestibular migraine: A systematic review and meta‐analysis	7
Baseline factors associated with post‐stenting intracranial pressure in patients with idiopathic intracranial hypertension with venous sinus stenosis	7
Lacosamide for refractory trigeminal neuralgia and other facial pain—Case report	7
Different characteristics of cortical spreading depression in the sleep and wake states	7
Habitual caffeinated beverage consumption and headaches among adults with episodic migraine: A prospective cohort study	7
Diagnostic accuracy of an artificial intelligence online engine in migraine: A multi‐center study	7
Correction to “A causative role for remote dural puncture and resultant arachnoid bleb in new daily persistent headache: A case report”	7
American Headache Society 67th Annual Scientific Meeting June 19–22, 2025 Minneapolis, Minnesota	7
Welcoming Headache's 2024 incoming class of Assistant Editors	7
Preliminary exploration of a multidimensional sleep health composite in adolescent females with frequent migraine	7
A placebo controlled, randomized clinical trial of galcanezumab for vestibular migraine: The INVESTMENT study	7
Plain Language Summary Publication: Regulation of headache response and transcriptomic network by the trigeminal ganglion clock	7
Learning headache triggers through experience: A laboratory study	7
Neuropathic changes in corneal nerve endings—A potential objective biomarker for migraine frequency and response to treatment	7
The impact of fear of attacks on pain‐related disability in cluster headache: Insights from the fear avoidance model	7
Evaluating associations of migraine‐related vertigo	7
Insight of a headache medicine provider in Indian Health Service: A personal and professional observation	7
The 15‐day threshold in the definition of chronic migraine is reasonable and sufficient—Five reasons for not changing the ICHD‐3 definition	7
Investigating the effects of weather on headache occurrence using a smartphone application and artificial intelligence: A retrospective observational cross‐sectional study	7
Good News? Bad News? Idiopathic intracranial hypertension and migraine	7
Multi‐region local field potential signatures and brain coherence alternations in response to nitroglycerin‐induced migraine attacks	7
Alterations in the structure and function of the brain in adolescents with new daily persistent headache: A pilot MRI study	7
Healthcare costs and resource utilization in patients with migraine treated with erenumab: A retrospective, non‐interventional study using claims data from the United States	7
Efficacy of an educational website on headaches in schoolchildren: A cluster‐randomized controlled trial	7
Headache neuroimaging: A survey of current practice, barriers, and facilitators to optimal use	6
Changes in migraine characteristics over 30 days of Ramadan fasting: A prospective study	6
Cost per treatment responder analysis of atogepant compared to rimegepant for the preventive treatment of episodic migraine	6
Management and outcomes of persistent headache after accidental dural puncture in the obstetric population: A 9‐year prospective audit	6
A qualitative evidence synthesis of patient perspectives on migraine treatment features and outcomes	6
Trainee highlights	6
Issue Information	6
A multicenter, randomized, double‐blind, placebo‐controlled, crossover trial to evaluate the efficacy and safety of zolmitriptan nasal spray for the acute treatment of migraine in patients aged 6 to 1	6
	6
New insight into the neural mechanisms of migraine in adolescents: Relationships with sleep	6
Pain medication beliefs in individuals with headache	6
Blood serum levels of PACAP and migraine onset: A systematic review and meta‐analysis of observational studies	6
Asking the right questions: The value of headache specialty care	6
Phenotype of midfacial pain in 12 new cases—A multidisciplinary idiopathic facial pain syndrome	6
Ramadan fasting in smokers with primary headache disorders: Impact of nicotine dependence on headache frequency and severity	6
	6
Efficacy of galcanezumab in proline‐rich transmembrane protein 2 (PRRT2)‐associated familial hemiplegic migraine: A case series	6
Patient preferences for preventive migraine treatments among Canadian adults: A discrete choice experiment	6
Altered brain functional connectivity in patients with tension‐type headache	6
	6
Sex influences the progression of cephalic mechanical and light hypersensitivities in a mouse model of chronic migraine	6
A rare case of lupus cerebritis presenting as ictal epileptic headache: A case report	6
AHS 2021 consensus on integrating new migraine therapies into clinical practice: Isn’t our goal choice of best therapy regardless of cost?	6
Sustained response of galcanezumab in migraine prevention: Patient‐level data from a post hoc analysis in patients with episodic or chronic migraine	6
The complex relationship between alcohol and migraine	6
A multicenter, prospective, single‐arm study of 60‐day peripheral nerve stimulation of the occipital nerves for the treatment of headache	6
Twenty twenty … two: Headache and COVID‐19	6
Changes in gamma‐aminobutyric acid and glutamate/glutamine levels in the right thalamus of patients with episodic and chronic migraine: A proton magnetic resonance spectroscopy study	6
Epidemiology, investigation, management, and outcome of headache in emergency departments (HEAD study)—A multinational observational study	6
Development and initial validation of the Kiswahili version of the Migraine Disability Assessment (MIDAS‐K) questionnaire	6
Spontaneous involution of a large pineal cyst: Case report and narrative review	6
Headache launches the publication of plain language summaries	6
Long‐term reductions in acute headache medication use after eptinezumab treatment in patients with migraine and prior preventive treatment failures: Post hoc analysis of the DELIVER randomi	6
Potential drug interaction between calcitonin gene‐related peptide antagonists and neonatal Fc receptor inhibitors	6
Challenges and complexities in designing cluster headache prevention clinical trials: A narrative review	6
Trainee highlights	6
Issue Information	6
Author response to comments on our article “Impact of perilesional edema on severity of migraine in patients with calcified neurocysticercosis: A prospective evaluation”	5
Circannual worsening in cluster headache correlates with daylight change	5
The 2022 Headache Editorial Board conflict of interest declarations	5
Diagnosis, consultation, treatment, and impact of migraine in the US: Results of the OVERCOME (US) study	5
Cardiovascular risk and triptan usage among patients with migraine	5
Safety of remote electrical neuromodulation for acute migraine treatment in pregnant women: A retrospective controlled survey‐study	5
Real world evidence of changes in CGRP monoclonal antibody and onabotulinumtoxinA prescription practices at the start of the COVID‐19 pandemic: An observational, retro	5
Basic Science Prize Award 2022	5
Occipital condyle syndrome due to small‐cell lung carcinoma: A case report	5
The management of trigeminal neuralgia with triptans, a narrative review of the literature	5
Headache associated with COVID‐19: Epidemiology, characteristics, pathophysiology, and management	5
Daith piercing: Revisited from the perspective of auricular acupuncture systems. A narrative review	5
Development of the Migraine‐Related Stigma (MiRS) Questionnaire: Results of the OVERCOME (US) Study	5
Implementing screening and treatment for adverse childhood experiences in pediatric patients with headache at the Children's Hospital of Philadelphia	5
	5
Adverse childhood experiences and onset of migraine in Canadian adolescents: A cohort study	5
American Headache Society white paper on treatment of post‐traumatic headache from concussion in youth	5